{"id":"https://openalex.org/W113483477","doi":null,"title":"Recent advances in biological therapy for inflammatory bowel disease.","display_name":"Recent advances in biological therapy for inflammatory bowel disease.","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W113483477","mag":"113483477","pmid":"https://pubmed.ncbi.nlm.nih.gov/15303463"},"language":"en","primary_location":{"id":"pmid:15303463","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15303463","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tropical gastroenterology : official journal of the Digestive Diseases Foundation","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010879779","display_name":"Jelica Kurtovic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108821","display_name":"Prince of Wales Hospital","ror":"https://ror.org/022arq532","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210108821"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jelica Kurtovic","raw_affiliation_strings":["Gastrointestinal and Liver unit, Prince of Wales Hospital, High Street, Randwick 2031, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal and Liver unit, Prince of Wales Hospital, High Street, Randwick 2031, Australia","institution_ids":["https://openalex.org/I4210108821"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045126203","display_name":"Isidor Segal","orcid":"https://orcid.org/0000-0003-1530-0199","observed_orcids":["https://orcid.org/0000-0003-1530-0199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isidor Segal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.0851,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.93153293,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"25","issue":"1","first_page":"9","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.7860000133514404},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":0.7799999713897705},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":1.0},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.8920000195503235},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9190000295639038},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.8379999995231628},{"id":"https://openalex.org/keywords/natalizumab","display_name":"natalizumab","score":0.9179999828338623},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.7850000262260437},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.925000011920929},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.9620000123977661},{"id":"https://openalex.org/keywords/interleukin-11","display_name":"interleukin-11","score":0.8349999785423279},{"id":"https://openalex.org/keywords/nf-kappab-inhibitors","display_name":"NF-\u03baB inhibitors","score":0.9049999713897705},{"id":"https://openalex.org/keywords/lymphocyte-trafficking","display_name":"lymphocyte migration","score":0.7900000214576721},{"id":"https://openalex.org/keywords/neutrophil-recruitment","display_name":"neutrophil recruitment","score":0.7250000238418579},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.7369999885559082},{"id":"https://openalex.org/keywords/interleukin-1","display_name":"interleukin-1","score":0.9660000205039978},{"id":"https://openalex.org/keywords/mucosal-inflammation","display_name":"mucosal inflammation","score":0.6539999842643738}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7639074325561523},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.7363454103469849},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6902626752853394},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.6413324475288391},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.5875449180603027},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5866370797157288},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.57904452085495},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5655977725982666},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.5037948489189148},{"id":"https://openalex.org/C2779719350","wikidata":"https://www.wikidata.org/wiki/Q412920","display_name":"Daclizumab","level":4,"score":0.4451856017112732},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.44083431363105774},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4366534948348999},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.38210564851760864},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13300666213035583},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.09300559759140015},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.07977545261383057}],"mesh":[{"descriptor_ui":"D000069442","descriptor_name":"Natalizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D015212","descriptor_name":"Inflammatory Bowel Diseases","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15303463","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15303463","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tropical gastroenterology : official journal of the Digestive Diseases Foundation","raw_type":"Journal Article"},{"id":"mag:113483477","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15303463","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W38202715","https://openalex.org/W2058250733","https://openalex.org/W1986962193","https://openalex.org/W3112205499","https://openalex.org/W2049333722","https://openalex.org/W2045938346","https://openalex.org/W2132632764","https://openalex.org/W51600446","https://openalex.org/W2317943954","https://openalex.org/W2031963525"],"abstract_inverted_index":{"Immune":[0],"system":[1],"is":[2,147],"a":[3,157],"major":[4],"determinant":[5],"of":[6,8,19,36,56,93,114,132,152,174,177,207,235,244,264],"pathophysiology":[7],"inflammatory":[9],"bowel":[10],"disease":[11,122],"(IBD),":[12],"and":[13,27,44,71,78,90,124,143,169,187,231,240,253,260,277],"cytokines":[14,26,43,77,135],"are":[15,97,196,209],"well":[16],"known":[17],"mediators":[18],"immune":[20],"system.":[21],"Recently,":[22],"informations":[23],"on":[24,83],"pro-inflammatory":[25],"their":[28],"role":[29],"in":[30,49,109,149,199],"IBD":[31,186,208],"have":[32,86,128],"led":[33],"to":[34,40],"development":[35],"potential":[37,101],"therapeutic":[38,52],"approach":[39,108],"manipulate":[41],"these":[42,84,100],"there":[45],"by":[46],"inhibiting":[47],"inflammation":[48,179],"IBD.":[50,112],"These":[51],"approaches":[53],"include":[54],"inhibitors":[55],"the":[57,91,115,150,175,182,192,205],"tumour":[58],"necrosis":[59],"factor":[60,73,266,275,280],"(TNF)-alpha":[61],"lymphocyte":[62,236],"trafficking,":[63],"type":[64,74],"1":[65],"T":[66],"helper":[67],"(Th1)":[68],"cell":[69],"polarization":[70],"nuclear":[72,265],"beta;":[75],"immunoregulatory":[76],"various":[79],"growth":[80,274,279],"factors.":[81],"Studies":[82],"therapies":[85,183,194,218],"documented":[87],"variable":[88],"results":[89,160],"outcomes":[92],"many":[94],"clinical":[95,200],"trials":[96],"awaited.":[98],"However,":[99],"therapies,":[102],"if":[103],"become":[104],"real":[105],"may":[106],"revolutionise":[107],"patients":[110,119],"with":[111,120],"Analysis":[113],"inflammed":[116,155],"mucosa":[117],"from":[118,161],"Crohn":[121],"(CD)":[123],"ulcerative":[125],"colitis":[126],"(UC)":[127],"shown":[129],"increased":[130],"expression":[131],"certain":[133],"proinflammatory":[134],"such":[136],"as":[137],"interleukin-1":[138],"(IL-1),":[139],"interleukin":[140],"6":[141],"(IL-6)":[142],"TNF-alpha.":[144],"The":[145,217],"latter":[146],"important":[148],"recruitment":[151],"neutrophils":[153],"into":[154],"tissue,":[156],"process":[158],"which":[159],"three":[162],"physiological":[163],"steps:":[164],"(i)":[165],"rolling,":[166],"(ii)":[167],"adhesion,":[168],"(iii)":[170],"transendothelial":[171],"migration.":[172],"Understanding":[173],"biology":[176],"chronic":[178],"has":[180],"expanded":[181],"available":[184],"for":[185,204,249],"particularly":[188],"CD.":[189],"At":[190],"present,":[191],"biological":[193],"that":[195],"being":[197],"used":[198,219],"practice":[201],"or":[202,215],"investigated":[203],"treatment":[206],"predominantly":[210],"proteins,":[211],"usually":[212],"delivered":[213],"intravenously":[214],"subcutaneously.":[216],"include:":[220],"1.":[221],"TNF-alpha":[222],"inhibitors:":[223],"infliximab,":[224],"CDP":[225],"571,":[226],"etanercept,":[227],"onercept,":[228],"CNI-":[229],"1493":[230],"thalidomide.":[232],"2.":[233],"Inhibitors":[234,243,263],"trafficking:":[237],"natalizumab,":[238],"LPD-02":[239],"ICAM-1.":[241],"3.":[242],"Th1":[245],"polarization:":[246],"monoclonal":[247],"antibodies":[248],"IL-12,":[250],"interferon":[251],"(IFN)-gamma":[252],"anti":[254],"IFN-gamma.":[255],"4.":[256],"Immunoregulatory":[257],"cytokines:":[258],"IL-10":[259],"IL-11.":[261],"5.":[262],"kappa":[267],"(beta":[268],"NF-kbeta.)":[269],"6.":[270],"Growth":[271],"factors:":[272],"epidermal":[273],"(EGF)":[276],"Keratinocyte":[278],"(KGF).":[281]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}